DOJ Alleges Kickbacks in Medicare Advantage Broker Commissions
The DOJ files a lawsuit accusing insurers and brokerages of illicit kickbacks in Medicare Advantage plan enrollments, raising compliance and regulatory concerns.
UnitedHealthcare Ends Commissions on Medicare Drug Plans Amid Rising Costs
UnitedHealthcare stops paying commissions on Medicare prescription drug plans sold after June 1, 2025, impacting agents amid rising Medicare Advantage costs and prompting calls for CMS intervention.
Judge Rejects Florida Blue’s Quest to Reevaluate Medicare Advantage Star Ratings
A federal judge denied Florida Blue's request to reconsider Medicare Advantage star ratings linked to Broward County's 2023 flooding, citing CMS's regulatory criteria for public health emergencies.
Impact of Private Equity on U.S. Healthcare Consolidation and Patient Care
Explore how private equity's rise in U.S. health care consolidation affects hospitals, physician practices, care quality, costs, and regulatory responses.
UnitedHealth Stock Decline Highlights Regulatory and Cost Challenges in Healthcare
UnitedHealth Group's 2025 stock decline reflects rising medical costs and DOJ investigations, impacting healthcare sector valuations and Dow index dynamics.
U.S. Healthcare and Insurance Update: Rural Access, Medicaid Policy, and Drug Regulation
Comprehensive update on critical U.S. healthcare and insurance issues including Medicaid policy, rural hospital challenges, Medicare Advantage scrutiny, FDA drug approvals, and public health dynamics.
UnitedHealth’s Medicare Advantage Challenges Signal Market Shift
UnitedHealth Group reports higher medical loss ratio and earnings challenges in Medicare Advantage, signaling a strategic shift amid rising care costs and regulatory scrutiny.
Optum Develops AI-Based Risk Coding for Medicare Patients Amid DOJ Scrutiny
Optum is creating AI-driven risk coding to improve Medicare patient assessments, coinciding with DOJ investigations into Medicare Advantage practices by UnitedHealth Group.
UnitedHealth Group Faces DOJ Medicare Fraud Probe Amid Leadership Changes
UnitedHealth Group is reportedly under a DOJ criminal investigation for Medicare fraud, adding to existing probes amid leadership and financial outlook shifts.
Medicare Inflation Rebates: Extending Protections to Medicare Advantage Enrollees
Analysis of inflation rebate implementation under the Inflation Reduction Act highlights the need to include Medicare Advantage enrollees to maximize drug cost savings and deter pharmaceutical price hikes.